India coronavirus diagnostics market is
anticipated to show a robust growth in the upcoming five years owing to the
emergence of the new strain of the virus that is rapidly spreading in the
country. The market is anticipated to show an impressive double digit CAGR in
the upcoming five years. Coronavirus is an infectious disease that affects the
lungs of the patients and causes breathing problems. The older strains of virus
in last decade were only responsible for common cold, or diseases like MERS,
and SARS. In the year, 2019 the virus first spread in Wuhan, China and within
next 3 months, it was announced to be the pandemic causing virus by March 2020
in the whole world. By the end of FY2021, India experienced the spread of a new
strain of corona virus, the threat has increased many folds than what it was in
the last year. This re-attack of the virus is directly driving the India
coronavirus diagnostics market and is anticipated to do so in the next five
years too.
Moreover, concerns among the Indian
population regarding the threat, is driving the growth of the India coronavirus
diagnostics market. Government is aiding the process of vaccination and free
drives of diagnostics continuously, thereby driving the growth of the market in
the upcoming five years.
India
coronavirus diagnostics market is segmented by type of test, user, full time
test, end user, regional distribution, and competitional landscape. Based on type of test the market is further
bifurcated into molecular and serological tests. Molecular tests for the
diagnosis of the coronavirus infection are anticipated to hold the larger share
of the market. Molecular tests involve the tests that are done through
processes like RT-PCR, CRISPR, LAMP, etc. These tests separate the viral genetic
material and immediately multiply the protein encoded in the genetic material
to identify the presence of virulent in human body, thereby diagnosing it. This
method is often quick and takes not more than 12 to 48 hours. Thus, the segment
is anticipated to dominate the market. Serological tests involve the testing of
antigen and antibody in the human body. The process of generation of antigen
and antibodies takes days and weeks to develop, and the identification becomes
difficult until late. Serological testing is not a viable option of an active
infection of COVID-19.
Some of the
top players in the India coronavirus diagnostics market are, Abbott
Laboratories India Ltd., Biomerieux India Private Limited, Bio-Rad Laboratories
India Pvt. Ltd., DHR Holding India Pvt Ltd., Roche Diagnostics India Pvt. Ltd.,
Pfizer India Ltd., Mylab Discovery Solutions Pvt. Ltd., Thermo Fisher
Scientific India Pvt. Ltd., CPC Diagnostics Pvt. Ltd., Zydus Cadila Ltd., among
others. The companies are involving themselves into research and development
for the methods of better quality, and various quality analysis tests to
provide the better products.
Years considered for this report:
Historical
Years: FY2017 – FY2020
Base Year:
FY2021
Estimated
Year: FY2022
Forecast
Period: FY2023 – FY2027
Objective of the
Study:
- To analyze the historical
growth of the market size of India coronavirus diagnostics market from
FY2017 to FY2020.
- To estimate and forecast
the market size of India coronavirus diagnostics market from FY2021 to
FY2027 and growth rate until FY2027.
- To classify and forecast India coronavirus
diagnostics market based on type of test, user, full test time, end user,
competitional landscape, and regional distribution.
- To identify dominant region or segment in the India coronavirus
diagnostics market.
- To identify drivers and
challenges for India coronavirus diagnostics market.
- To examine competitive
developments such as expansions, new product launches, mergers &
acquisitions, etc., in India coronavirus diagnostics market.
- To
identify and analyze the profile of leading players operating in India coronavirus
diagnostics market.
- To identify key sustainable strategies adopted by market players in
India coronavirus diagnostics market.

Click here to download the sample
TechSci Research
performed both primary as well as exhaustive secondary research for this study.
Initially, TechSci Research sourced a list of manufacturers, suppliers, and
service providers across the country. Subsequently, TechSci Research conducted
primary research surveys with the identified companies. While interviewing, the
respondents were also enquired about their competitors. Through this technique,
TechSci Research could include the manufactures which could not be identified
due to the limitations of secondary research. TechSci Research analyzed the manufactures,
distribution channels and presence of all major players across the country.
TechSci Research
calculated the market size of India coronavirus diagnostics market
using a bottom-up approach, wherein data for various end-user segments was
recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analysing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Manufacturers, end users, and
other stakeholders
- Distributers and suppliers of coronavirus
diagnostics and other stakeholders
- Organizations, forums, and
alliances related to coronavirus diagnostics
- Market research and consulting
firms
The study is
useful in providing answers to several critical questions that are important
for the industry stakeholders such as manufacturers, suppliers, end users,
etc., besides allowing them in strategizing investments and capitalizing on
market opportunities.
Report
Scope:
In this
report, India Coronavirus Diagnostics market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Coronavirus Diagnostics Market, By Type
of Test:
- India Coronavirus
Diagnostics Market, By User:
o
Single
o
Multiple
- India
Coronavirus Diagnostics Market, By Full Test Time:
- Less Than
60 Minutes
- 1 Hours to
12 Hours
- 13
Hours-24Hours
- More Than
1 Day
- India Coronavirus
Diagnostics Market, By End User:
o
Hospitals
o
Public Health Labs
o
Private or Commercial Labs
o
Physician Labs
o
Others
- India Coronavirus
Diagnostics Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis
of the major companies present in India Coronavirus
Diagnostics market.
Available
Customizations:
With the given
market data, TechSci Research offers customizations according to a company’s
specific needs. The following customization options are available for the
report:
Company Information
- Detailed analysis and profiling of
additional market players (up to five).
India Coronavirus
Diagnostics Market is an upcoming report to be released soon. If you wish an
early delivery of this report or want to confirm the date of release, please
contact us at [email protected]